John Keane, Co-Founder and CEO
John is a medical device executive with three decades of experience developing and commercializing emerging medical technologies. Having been involved in more than 30 product launches with a focus on neurological disorders, he brings a wealth of knowledge on product development, delivering clinical value and gaining adoption in the marketplace. As a strategic leader and advisor to multiple companies, John has proven success in defining vision and positioning companies for dynamic gains.
John sees beyond the status quo to identify and get to the heart of issues; stroke is a universal problem and John with his co-founders are focused on reducing time to treatment of Large Vessel Occlusion stroke by properly triaging patients in the prehospital setting.
“MindRhythm differentiates itself from anything else on the market. It provides a solution for a known problem, where nothing currently exists."
Paul Lovoi, PhD, Co-Founder and CTO
A serial entrepreneur, Paul has founded and funded eight companies in diverse fields including flat panel displays, laser paint stripping, oncology, cardiology, and stroke triage. With 43 years of experience inventing solutions to significant problems in technology and medicine, Paul is backed by a demonstrated track record of translating those solutions into the clinic. He is dedicated to guiding teams in new product development and working around solutions to make significant shifts in technology and markets.
Following the death of his wife due to a stroke, Paul was determined to prevent this from happening to others. In discovering the Headpulse algorithm, he found a way to accurately diagnose stroke in a non-invasive manner leading him to form MindRhythm.
“The device technology is a groundbreaking effect of the innovative product development and clinical proficiency from a team dedicated to lifesaving, diagnostic treatments. Seeing that solutions are made and brought into the marketplace in preventing stroke complications is at the utmost importance."
Wade Smith, MD, PhD, Co-Founder and Chair of the Scientific Advisory Board
Professor Smith is a Neurocritical care physician and the Chief of the Neurovascular Division at UCSF. The primary focus of his research career has been to develop novel treatments for stroke - specifically thrombectomy - and he is now innovating stroke triage to bring life-saving care to all citizens. Dr. Smith designed device prototypes and co-developed the artificial intelligence algorithms that form the foundation for MindRhythm's technology. Dr. Smith brings vast experience in stroke management as well as clinical trial design and FDA expertise. His clinical guidance will ensure that MindRhythm achieves its goal of reducing morbidity and mortality in stroke.
“We have the tools and manpower to treat the most serious form of ischemic stroke. However, in order to treat a patient, we have to get them from home or work to the closest hospital that can treat them because not all hospitals have these treatments. Currently, paramedics do not have the tools they need to make this decision. MindRhythm solves this problem by providing a novel, portable, inexpensive device that helps identify which stroke patient will benefit from these new treatments and locates the closest eligible hospital to treat them.”
